« Previous
Next »
Journal of Reproductive Immunology
Volume 78, Issue 2
, Pages 115-124
, July 2008
Fusion of hC3d3 to hCGβ enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge
References
- . Complement dependent trapping of infectious HIV in human lymphoid tissues. AIDS. 2005;19:481–486
- . Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines. Scand. J. Immunol. 2005;61:322–328
- . The role of complement in B cell activation and tolerance. Adv. Immunol. 2000;74:61–88
- . CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 1992;256:105–107
- . Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 1988;141:457–463
- . Assays of antibodies to a C-terminal peptide or the entire β-subunit of human chorionic gonadotropin. J. Clin. Lab. Anal. 1998;12:60–64
- . The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity. 2001;14:169–179
- . C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 1996;271:348–350
- . Follicular dendritic cell accessory activity crosses MHC and species barriers. Eur. J. Immunol. 2001;31:176–185
- . Identification of murine complement receptor type 2. Proc. Natl. Acad. Sci. U.S.A. 1989;86:242–246
- . Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science. 1998;280:582–585
- . C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine. 2002;20:242–248
- . Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J. Virol. 2003;77:2046–2055
- . Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J. Immunol. 2004;172:5833–5837
- . Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 1998;160:1565–1672
- . Gene fusion of molecular adjuvant C3d to hCGβ enhances the anti-hCGβ antibody response in DNA immunization. J. Reprod. Immunol. 2003;60:129–141
- . Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway. J. Immunol. 2005;174:3264–3272
- . Designing an effective immunocontraceptive. J. Reprod. Immunol. 1997;36:51–59
- . Lipid rafts and B-cell activation. Nat. Rev. Immunol. 2002;2:96–105
- . Immunological hazards associated with vaccination of humans. J. Autoimmun. 2000;14:11–13
- . C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 2000;1:127–131
- . Antifertility vaccines. In: Perlmann P, Wigzell H editor. Handbook of Experimental Pharmacology. Springer-Verlag; 1999;p. 443–461
- . A vaccine that prevents pregnancy in women. Proc. Natl. Acad. Sci. U.S.A. 1994;91:8532–8536
- . Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers. Immunol. Rev. 1999;171:173–192
- . DNA immunization with plasmids expressing hCGbeta-chimeras. Vaccine. 2004;22:2146–2153
- . Enhancement of humoral immunity to the hCG beta protein antigen by fusing a molecular adjuvant C3d3. J. Reprod. Immunol. 2004;63:97–110
- . Gene conjugation of molecular adjuvant C3d3 to hCGβ increased the anti-hCGβ Th2 and humoral immune response in DNA immunization. J. Gene Med. 2006;8:498–505
- . Molecular adjuvant C3d up-regulates both B7-1 and B7-2 expression on Raji cells. J. Mol. Cell. Biol. 2006;39:77–82
PII: S0165-0378(08)00028-4
doi: 10.1016/j.jri.2008.03.004
© 2008 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Journal of Reproductive Immunology
Volume 78, Issue 2
, Pages 115-124
, July 2008
